Citadel Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | $585K | Sell |
|
|||||
|
2024
Q3 | $3.98M | Buy |
|
|||||
|
2024
Q2 | $812K | Sell |
|
|||||
|
2024
Q1 | $1.33M | Buy |
|
|||||
|
2023
Q4 | $105K | Sell |
|
|||||
|
2023
Q3 | $2.86M | Buy |
|
|||||
|
2023
Q2 | $242K | Sell |
|
|||||
|
2023
Q1 | $1.35M | Buy |
|
|||||
|
2022
Q4 | $19.7K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $212K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $226K | Sell |
|
|||||
|
2021
Q3 | $623K | Sell |
|
|||||
|
2021
Q2 | $2.72M | Buy |
|
|||||
|
2021
Q1 | $321K | Sell |
|
|||||
|
2020
Q4 | $401K | Buy |
|
|||||
|
2020
Q3 | $246K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $308K | Buy |
|